News & Perspective

Feb 01, 2019

Feb 01, 2019

ASP Scan (Weekly) for Feb 01, 2019

Animal stewardship partnership
Antibiotic pipeline details
New PACCARB members
Decline in UK antibiotics
Superbug bloodstream infections in Greece
Antibiotics and malaria prevention
Promising antifungal candidate
Proposed UN AMR guidance
Proposed UN AMR guidance
Antibiotic use in nursing homes
Novel antibiotic vs C diff
Pharmacist interventions
Antibiotics for asthma attack

Aug 10, 2018

Aug 10, 2018

ASP Scan (Weekly) for Aug 10, 2018

Cost of antibiotic resistance
Antibiotic resistance in Australia
New antibiotic for pneumonia, skin infections
Ventilator-associated pneumonia risk factors
Autism and early antibiotic exposure
Stewardship standouts
AMR innovation competition
Phased stewardship strategy
Antibiotic use in the Amazon

Jun 29, 2018

Jun 29, 2018

ASP Scan (Weekly) for Jun 29, 2018

FDA guidance for reporting animal antimicrobial sales
VIM-CRE in Indiana hospitals
Resistant bugs in meat
UTI prophylactic antibiotics and resistance
Antibiotic stewardship financial incentives
New drug-resistant UTI treatment
Updated infectious disease lab testing guide
Letter-based antibiotic prescribing intervention
CMS proposes less hospital infection reporting

Jun 28, 2018

Jun 28, 2018

Stewardship / Resistance Scan for Jun 28, 2018

Antibiotic stewardship financial incentives
New drug-resistant UTI treatment
Updated infectious disease lab testing guide

Jun 30, 2017

Jun 30, 2017

ASP Scan (Weekly) for Jun 30, 2017

Students' antibiotic knowledge
MCR-1 in Portugal
Opposition to AMR budget cuts
Antibiotics for skin wounds
Antibiotic resistance at the Hajj
C diff in cancer patients
Contact precautions for MRSA
Antibiotic-resistant acne

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»